These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7993838)

  • 21. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
    Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
    Zhou J; Xiong Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):90-3. PubMed ID: 7657349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
    Carney DN; Marangos PJ; Ihde DC; Bunn PA; Cohen MH; Minna JD; Gazdar AF
    Lancet; 1982 Mar; 1(8272):583-5. PubMed ID: 6121182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
    Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
    Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer.
    Adewole IF; Newlands ES
    Med Oncol Tumor Pharmacother; 1987; 4(1):11-5. PubMed ID: 3037205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The usefulness of serum neuron-specific enolase in the clinical management of small-cell lung carcinoma].
    Sánchez de Cos Escuín J; Masa Jiménez F; Disdier Vicente C; de la Cruz Ríos JL; Vergara Fiordia C; Domínguez Retortillo C; Fuentes Otero F
    Arch Bronconeumol; 1994 Oct; 30(8):375-80. PubMed ID: 7987543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
    Jørgensen LG; Hirsch FR; Skov BG; Osterlind K; Cooper EH; Larsson LI
    Br J Cancer; 1991 Jan; 63(1):151-3. PubMed ID: 1703432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.
    Body JJ; Paesmans M; Sculier JP; Dabouis G; Bureau G; Libert P; Berchier MC; Raymakers N; Klastersky J
    Clin Chem; 1992 May; 38(5):748-51. PubMed ID: 1316245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.
    van Zandwijk N; Jassem E; Bonfrer JM; van Tinteren H
    Eur J Cancer; 1990 Mar; 26(3):373-6. PubMed ID: 2162690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
    Akoun GM; Scarna HM; Milleron BJ; Bénichou MP; Herman DP
    Chest; 1985 Jan; 87(1):39-43. PubMed ID: 2981171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.
    Esscher T; Steinholtz L; Bergh J; Nöu E; Nilsson K; Påhlman S
    Thorax; 1985 Feb; 40(2):85-90. PubMed ID: 2983452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
    Kobayashi S; Okada S; Hasumi T; Sato N; Fujimura S
    Tohoku J Exp Med; 1999 Sep; 189(1):37-49. PubMed ID: 10622207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
    Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P
    Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
    Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel, Fully Human Anti-fucosyl-GM1 Antibody Demonstrates Potent
    Ponath P; Menezes D; Pan C; Chen B; Oyasu M; Strachan D; LeBlanc H; Sun H; Wang XT; Rangan VS; Deshpande S; Cristea S; Park KS; Sage J; Cardarelli PM
    Clin Cancer Res; 2018 Oct; 24(20):5178-5189. PubMed ID: 30021910
    [No Abstract]   [Full Text] [Related]  

  • 38. Validation of an algorithm able to differentiate small-cell lung cancer (SCLC) from non-small-cell lung cancer (NSCLC) patients by means of a tumour marker panel: analysis of the errors.
    Paone G; De Angelis G; Portalone L; Greco S; Giosué S; Taglienti A; Bisetti A; Ameglio F
    Br J Cancer; 1997; 75(3):448-50. PubMed ID: 9020496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
    Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
    Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.